BARI 2D: A Reanalysis Focusing on Cardiovascular Events-Reference-Cited by-同舟云学术

BARI 2D: A Reanalysis Focusing on Cardiovascular Events

Published:2019-11 Issue:11 Volume:94 Page:2249-2262
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Genuth Saul M.,Vlachos Helen,Brooks Maria Mori,Bantle John P.,Chaitman Bernard R.,Green Jennifer,Kelsey Sheryl F.,King Spencer B.,McBane Robert,Sako Edward Y.^ORCID,Schneider David J.,Steffes Michael,Frye Robert L.^ORCID

Funder

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Sanofi

National Institutes of Health

NIH

Saint Louis University

Glaxo

Publisher

Elsevier BV

Subject

General Medicine

Reference45 articles.

1. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes;Morrish;Diabetologia,2001

2. Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting;Aronson;Rev Endocr Metab Disord,2010

3. Coronary revascularization in diabetic patients: a systematic review and Bayesian network meta-analysis;Tu;Ann Intern Med,2014

4. Comparison of coronary artery bypass graft surgery and percutaneous coronary intervention in patients with diabetes;Toklu;Curr Treat Options Cardiovasc Med,2015

5. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning reveals serum myristic acid, palmitic acid and heptanoylcarnitine as biomarkers of coronary artery disease risk in patients with type 2 diabetes mellitus;Clinica Chimica Acta;2024-03

2. PREVALENCE OF TRADITIONAL CARDIOVASCULAR RISK FACTORS FOR CORONARY ARTERY DISEASE AND ELEVATED FIBRINOGEN AMONG ACTIVE MILITARY PERSONNEL IN REPUBLIC OF SERBIA: A CROSS-SECTIONAL STUDY;Journal of Medical Biochemistry;2021-11-12

3. Treatment Strategies in Patients with Diabetes Mellitus and Ischemic Heart Disease;Clinical Dilemmas in Diabetes;2021-11-05